SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bosco & Crossy's stock picks,talk area -- Ignore unavailable to you. Want to Upgrade?

To: JoeinIowa who wrote (3608)7/15/2003 8:39:51 PM
From: Crossy  Read Replies (1) | Respond to of 37387
 
Joe,
I do knwo that there is the "submicrobiotical" dosage that this hinges upon, the specifics that you cite I wasn't aware. Now CGPI is way more than just Periostat (Dosycicline) and I wonder what "expanded label usage" for Rosecea will do for them. I guess one could take the generic either just cannot prescribe it for Rosecea.. <g>

rgrds
cROSSY



To: JoeinIowa who wrote (3608)7/16/2003 6:16:48 PM
From: Jeffrey Beckman  Respond to of 37387
 
I asked my dentist about Periostat for the normal indications awhile back. He suggested it was, in his opinion, of doubtful benefit and doesn't prescribe it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News